By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

A new study found that combining two treatments—one that fixes the faulty SMN2 gene and another that blocks an enzyme called HDAC6—greatly improved muscle strength and survival in a mouse model of spinal muscular atrophy (SMA). This is important because it offers a potential way to help SMA patients who still face muscle weakness even after receiving newer gene therapies.

This week’s Medicine Key Highlights

This week’s Medicine Key Highlights

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Science Briefing

Medicine

Science Briefing

Last updated: May 4, 2026 9:46 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•

 

No articles matching the subfield ‘Diabetes’ or explicitly covering topics like diabetic nephropathy or diabetic foot care were found in the provided dataset.
Source →


Stay curious. Stay informed —
Science Briefing

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Science Briefing
Next Article A new blood test called “MethylCog” uses 29 DNA methylation markers from a blood sample to predict general cognitive ability, and was shown to help distinguish people with mild cognitive impairment (MCI) from healthy individuals, improving detection accuracy beyond age and sex alone. This blood-based biomarker offers a scalable and easy-to-use tool that could help identify those at risk for dementia, especially in settings where direct cognitive testing is not possible.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Today’s Diabetes Science Briefing | April 23rd 2026, 9:00:12 am

Brazil’s community health workers go global—England borrows a playbook on equity

Today’s Diabetes Science Briefing | March 19th 2026, 1:00:12 pm

Invisible Threats, Visible Consequences: The Metabolomic Link Between Air Pollution and Heart Failure

Mapping the Brain’s Battlefield: Where Alzheimer’s Antibodies Actually Go

The March 2026 Oncology Agenda: A Preview of Forthcoming Research

A New Sonographic Tool for Sentinel Lymph Node Assessment in Gynecologic Cancers

Brain Scans Reveal a Dynamic Link Between Tiny Strokes and Dementia Risk

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Energy
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?